首页> 外文期刊>Кардиология >DOUBLE BLOCKADE OF ALDOSTERONE RECEPTORS AS A METHOD OF ELIMINATION NEGATIVE EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN CHRONIC HEART FAILURE
【24h】

DOUBLE BLOCKADE OF ALDOSTERONE RECEPTORS AS A METHOD OF ELIMINATION NEGATIVE EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN CHRONIC HEART FAILURE

机译:双阻断醛固酮受体作为消除非甾体抗炎药对慢性心力衰竭的负面影响的方法

获取原文
获取原文并翻译 | 示例
           

摘要

The article deals with the dynamics of echocardioscopy indices during 1.5 years in a patient who underwent an acute myocardial infarction (MI). Two months after the MI left ventricular (LV) end-diastolic size and LV volume were 61 mm and 190 ml, respectively; LV ejection fraction (EF) was 42%. At the background of maximal possible doses of ramipril, bisoprolol, and selective antagonist of aldosterone receptors eplerenone, and after revascularization, within eight months LV end-diastolic size decreased down to 57 mm, LV volume - to 158 ml, and LVEF increased up to 51%. There was no change of potassium and creatinine blood serum levels. The situation changed dramatically after addition to ongoing therapy because of exacerbation of chronic osteochondrosis of ketoprofen 100, meloxicam 15 and tolperisone (Mydocalm) 450 mg/day. The patient noted an increase in dyspnea during walking, a decrease in exercise tolerance. LVEF fell to 36%, LV size increased up to values registered in 2 months after MI. There were no signs of overt fluid retention (no gain of weight, lower limbs edema, lung congestion on X-ray, hepatomegaly at ultrasound examination). In 4 months after addition to therapy of a loop diuretic torasemide (5 mg) the cardio-hemodynamic parameters almost returned to values prior to administration of anti-inflammatory drugs. Conclusion. Loop diuretic (such as torasemide) can be recommended for elimination of negative consequences of the use of nonsteroidal anti-inflammatory drugs in patients with chronic heart failure.
机译:本文涉及在患有急性心肌梗死(MI)的患者中1.5岁的超声心动镜检查索引的动态。 MI左心室(LV)末端舒张尺寸和LV体积分别为61mm和190ml后两个月; LV喷射分数(EF)为42%。在最大可能剂量的ramipril,bisoprolol和醛固酮受体eplerenone的选择性拮抗剂的背景下,并且在血运重建后,在八个月内,LV端舒张尺寸下降至57mm,LV体积 - 至158ml,并且LVEF增加到158毫升51%。钾和肌酐血清水平没有变化。除了加剧酮洛芬100,美洛昔康15和甲苯胺(Mydocalm)450mg /天的慢性骨骨髓症,持续治疗后,情况发生了急剧改变。患者在行走期间注意到呼吸困难增加,运动耐受性降低。 LVEF降至36%,LV大小增加到MI后2个月内注册的价值。没有明显的液体保留迹象(没有增长的重量,下肢水肿,X射线上的肺充血,超声检查肝脏肿瘤)。在除了治疗Loop利尿扭矩(5mg)后的4个月内,心动力学参数几乎返回给施用抗炎药物之前的值。结论。环路利尿剂(如托雷索米德)可以建议消除使用非甾体抗炎药物在慢性心力衰竭患者中使用的负面后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号